Realworld Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients [0.03%]
延长Letermovir预防allo-HSCT受者的疗效和安全性：一项真实世界研究
Yasutaka Masuda,Takashi Toya,Riki Yamakawa et al.
Yasutaka Masuda et al.
Background: Cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell transplantation (HSCT) leads to significant morbidity and mortality. Recently, a pivotal trial demonstrated extended duration of ...
Safety and Efficacy of MV140 Sublingual Vaccine (Uromune) in Preventing Recurrent Urine Infections Post Renal Transplant: A Case Series [0.03%]
舌下滴入MV140疫苗（UROMUNE）预防肾移植后复发性尿路感染的疗效及安全性：病例系列报告
Benjamin Palladino,Devin O&#x;Shea-Farren,Peter Boan et al.
Benjamin Palladino et al.
Respiratory Syncytial Virus Exceeded SARS-CoV-2 and Influenza in Lower Respiratory Infection and Mortality Rates Among Patients With Hematologic Malignancies During the 2023-2024 Respiratory Virus Season [0.03%]
在2023-2024年呼吸道病毒季节中，呼吸合胞病毒引起的血液系统恶性肿瘤患者的下呼吸道感染和死亡率超过了SARS-CoV-2和流感病毒感染所致的水平
Tali Shafat,Amy Spallone,Fareed Khawaja et al.
Tali Shafat et al.
Background: Respiratory viral infections (RVIs) significantly impact patients with hematologic malignancies (HMs). During the 2023-2024 respiratory viral (RV) season, we observed a decline in SARS-CoV-2-related hospitaliz...
Prolonged Trimethoprim-Sulfametoxazole Prophylaxis in Kidney Transplant Recipients: Is it Justified by the "Collateral Benefits"? [0.03%]
肾移植受者的长期甲氧苄氨嘧啶-磺胺甲恶唑预防：是否因“连带效应”而合理？
Belén Gutierrez-Gutierrez,Julián Torre-Cisneros,Juan José Castón
Belén Gutierrez-Gutierrez
Donor-Derived Disseminated Amebiasis of Balamuthia mandrillaris After Kidney Transplant [0.03%]
一例移植术后鲍曼amoeba脑炎患者的供者来源播散性阿米巴病
Kolby Quillin,Nicole Dominiak,Obi Ekwenna
Kolby Quillin
Karim A Elyamany,Ravi V Durvasula,Sammer M Elwasila et al.
Karim A Elyamany et al.
The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified-Release Posaconazole Prophylaxis [0.03%]
改良释放型泊沙康唑预防下的异基因造血干细胞移植受者侵袭性真菌突破感染的流行病学变化趋势分析
Shio Yen Tio,Chin Fen Neoh,David Ritchie et al.
Shio Yen Tio et al.
Background: Allogeneic hemopoietic stem cell transplant (aHSCT) recipients are at high-risk for invasive fungal disease (IFD), even with mould-active antifungal prophylaxis (AFP). ...
Cowdry A Bodies of Varicella Zoster Virus in a Renal Transplant Recipient [0.03%]
器官移植患者的水痘病毒 Cowdry A 体
Kiran Gajurel,Gautam M Phadke,Muammar Arida
Kiran Gajurel
NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients [0.03%]
努特15基因多态性作为预防性缬更昔洛韦致肺移植患者早期中性粒细胞减少的风险因素
Yurie Katsube,Keisuke Umemura,Yuzuki Urabe et al.
Yurie Katsube et al.
Background: Valganciclovir (VGCV) prophylaxis effectively prevents cytomegalovirus infection in lung transplant patients. However, VGCV-induced neutropenia causes early cessation. Nucleoside diphosphate-linked moiety X-ty...
Chelsea A Gorsline,Courtney E Harris,Stella Radosta et al.
Chelsea A Gorsline et al.
The landscape of transplant infectious diseases (TID) is changing rapidly, with many new and exciting ideas on the horizon. A live #TxIDChat on the social media platform Bluesky by the TID Early Career Network was conducted on hot topics in...